These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 12235243)

  • 1. In vivo characterization of the mitochondrial selective K(ATP) opener (3R)-trans-4-((4-chlorophenyl)-N-(1H-imidazol-2-ylmethyl)dimethyl-2H-1-benzopyran-6-carbonitril monohydrochloride (BMS-191095): cardioprotective, hemodynamic, and electrophysiological effects.
    Grover GJ; D'Alonzo AJ; Darbenzio RB; Parham CS; Hess TA; Bathala MS
    J Pharmacol Exp Ther; 2002 Oct; 303(1):132-40. PubMed ID: 12235243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic characterization of BMS-191095, a mitochondrial K(ATP) opener with no peripheral vasodilator or cardiac action potential shortening activity.
    Grover GJ; D'Alonzo AJ; Garlid KD; Bajgar R; Lodge NJ; Sleph PG; Darbenzio RB; Hess TA; Smith MA; Paucek P; Atwal KS
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1184-92. PubMed ID: 11356945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of ventricular proarrhythmia with selective opening of the myocardial sarcolemmal versus mitochondrial ATP-gated potassium channel.
    Fischbach PS; White A; Barrett TD; Lucchesi BR
    J Pharmacol Exp Ther; 2004 May; 309(2):554-9. PubMed ID: 14747611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiomyocyte mitochondrial KATP channels participate in the antiarrhythmic and antiinfarct effects of KATP activators during ischemia and reperfusion in an intact anesthetized rabbit model.
    Das B; Sarkar C
    Pol J Pharmacol; 2003; 55(5):771-86. PubMed ID: 14704474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BMS-180448, a novel glyburide-reversible cardioprotective agent, enhances postischemic recovery of contractile function in dogs.
    Grover GJ; Parham CS; Whigan DB; Mitroka JG
    J Pharmacol Exp Ther; 1996 Feb; 276(2):380-7. PubMed ID: 8632300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KR-31762, a novel KATP channel opener, exerts cardioprotective effects by opening SarcKATP channels in rat models of ischemia/reperfusion-induced heart injury.
    Lee SH; Yang MK; Lim JH; Seo HW; Yi KY; Yoo SE; Lee BH; Won HS; Lee CS; Choi WS; Shin HS
    Arch Pharm Res; 2008 Apr; 31(4):482-9. PubMed ID: 18449506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vardenafil: a novel type 5 phosphodiesterase inhibitor reduces myocardial infarct size following ischemia/reperfusion injury via opening of mitochondrial K(ATP) channels in rabbits.
    Salloum FN; Ockaili RA; Wittkamp M; Marwaha VR; Kukreja RC
    J Mol Cell Cardiol; 2006 Mar; 40(3):405-11. PubMed ID: 16480739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic profile of the selective mitochondrial-K(ATP) opener BMS-191095 for treatment of acute myocardial ischemia.
    Grover GJ; Atwal KS
    Cardiovasc Drug Rev; 2002; 20(2):121-36. PubMed ID: 12177690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glyburide-reversible cardioprotective effect of BMS-180448 is independent of action potential shortening.
    Grover GJ; D'Alonzo AJ; Hess T; Sleph PG; Darbenzio RB
    Cardiovasc Res; 1995 Nov; 30(5):731-8. PubMed ID: 8595620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mitochondrial K(ATP) channel opener BMS-191095 reduces neuronal damage after transient focal cerebral ischemia in rats.
    Mayanagi K; Gáspár T; Katakam PV; Kis B; Busija DW
    J Cereb Blood Flow Metab; 2007 Feb; 27(2):348-55. PubMed ID: 16736040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial K(ATP) channel opening is important during index ischemia and following myocardial reperfusion in ischemic preconditioned rat hearts.
    Fryer RM; Hsu AK; Gross GJ
    J Mol Cell Cardiol; 2001 Apr; 33(4):831-4. PubMed ID: 11273735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardioselective antiischemic ATP-sensitive potassium channel (K(ATP)) openers. 6. Effect of modifications at C6 of benzopyranyl cyanoguanidines.
    Ding CZ; Rovnyak GC; Misra RN; Grover GJ; Miller AV; Ahmed SZ; Kelly Y; Normandin DE; Sleph PG; Atwal KS
    J Med Chem; 1999 Sep; 42(18):3711-7. PubMed ID: 10479302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GSK3beta inhibition and K(ATP) channel opening mediate acute opioid-induced cardioprotection at reperfusion.
    Gross ER; Hsu AK; Gross GJ
    Basic Res Cardiol; 2007 Jul; 102(4):341-9. PubMed ID: 17450314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BMS-191095, a cardioselective mitochondrial K(ATP) opener, inhibits human platelet aggregation by opening mitochondrial K(ATP) channels.
    Cho MR; Park JW; Jung IS; Yi KY; Yoo SE; Chung HJ; Yun YP; Kwon SH; Shin HS
    Arch Pharm Res; 2005 Jan; 28(1):61-7. PubMed ID: 15742810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and selective coronary vasodilatory activity of 3,4-dihydro-2,2-bis(methoxymethyl)-2H-1-benzopyran-3-ol derivatives: novel potassium channel openers.
    Cho H; Katoh S; Sayama S; Murakami K; Nakanishi H; Kajimoto Y; Ueno H; Kawasaki H; Aisaka K; Uchida I
    J Med Chem; 1996 Sep; 39(19):3797-805. PubMed ID: 8809167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-ischemic properties of a new spiro-cyclic benzopyran activator of the cardiac mito-KATP channel.
    Calderone V; Testai L; Martelli A; Rapposelli S; Digiacomo M; Balsamo A; Breschi MC
    Biochem Pharmacol; 2010 Jan; 79(1):39-47. PubMed ID: 19660436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tyrosine phosphatase inhibitor bis(maltolato)oxovanadium attenuates myocardial reperfusion injury by opening ATP-sensitive potassium channels.
    Liem DA; Gho CC; Gho BC; Kazim S; Manintveld OC; Verdouw PD; Duncker DJ
    J Pharmacol Exp Ther; 2004 Jun; 309(3):1256-62. PubMed ID: 14993257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial K ATP channel activation is important in the antiarrhythmic and cardioprotective effects of non-hypotensive doses of nicorandil and cromakalim during ischemia/reperfusion: a study in an intact anesthetized rabbit model.
    Das B; Sarkar C
    Pharmacol Res; 2003 Jun; 47(6):447-61. PubMed ID: 12741997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antihypertensive and cardioprotective effects of (-)-MJ-451, an ATP-sensitive K(+) channel opener.
    Lee YM; Yen MH; Peng YY; Sheu JR; Chen YC; Chang MJ; Cheng CY
    Eur J Pharmacol; 2000 May; 397(1):151-60. PubMed ID: 10844109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardioprotective effects of (2S,3R,4S)-N'-benzyl-N"-cyano-N-(3,4-dihydro-2-dimethoxymethyl-3-hydroxy-2-methyl-6-nitro-2H-benzopyran-4-yl)-guanidine (KR-31372) in rats and dogs.
    Lee BH; Seo HW; Yoo SE
    Pharmacology; 2004 Feb; 70(2):74-82. PubMed ID: 14685010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.